Bio-Techne (BSP:T1CH34) Pretax Margin % : 12.25% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Bio-Techne's Pre-Tax Income for the three months ended in Dec. 2023 was R$164 Mil. Bio-Techne's Revenue for the three months ended in Dec. 2023 was R$1,336 Mil. Therefore, Bio-Techne's pretax margin for the quarter that ended in Dec. 2023 was 12.25%.

The historical rank and industry rank for Bio-Techne's Pretax Margin % or its related term are showing as below:

BSP:T1CH34' s Pretax Margin % Range Over the Past 10 Years
Min: 15.69 Med: 28.41 Max: 45.11
Current: 21.96

BSP:T1CH34's Pretax Margin % is ranked better than
88.61% of 1027 companies
in the Biotechnology industry
Industry Median: -176.72 vs BSP:T1CH34: 21.96

Bio-Techne Pretax Margin % Historical Data

The historical data trend for Bio-Techne's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Pretax Margin % Chart

Bio-Techne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pretax Margin %

Get a 7-Day Free Trial

15.69

37.43

15.92

27.26

29.79

Bio-Techne Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pretax Margin %	Get a 7-Day Free Trial															24.46	27.26	29.31	17.90	12.25

Competitive Comparison of Bio-Techne's Pretax Margin %

For the Biotechnology subindustry, Bio-Techne's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Techne's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Pretax Margin % falls into.

Bio-Techne Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Bio-Techne's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	1643.749	/	5517.21
	=	29.79 %

Bio-Techne's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	163.59	/	1335.676
	=	12.25 %

Bio-Techne (BSP:T1CH34) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Bio-Techne Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne (BSP:T1CH34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

TECH:USA TE1:Germany

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne (BSP:T1CH34) Headlines

No Headlines